Free Newsletter
Register for our Free Newsletters
Newsletter
Zones
Analysis, Inspection and Laboratory
LeftNav
Assisted/Independent Living
LeftNav
Clinical and Nursing Equipment
LeftNav
Design and Manufacture of Medical Equipment
LeftNav
Diagnostics Equipment, Monitoring and Test
LeftNav
Education, Training and Professional Services
LeftNav
Health Education and Patient Management
LeftNav
Health Estates Management
LeftNav
Healthcare Support and Information Services
LeftNav
Hygiene and Infection Control
LeftNav
IT and Communications in Healthcare
LeftNav
Materials
LeftNav
Medical Device Technology
LeftNav
Research and Development
LeftNav
Safety and Security
LeftNav
View All
Other Carouselweb publications
Carousel Web
Defense File
New Materials
Pro Health Zone
Pro Health Zone
Pro Security Zone
Web Lec
Pro Engineering Zone
 
 
News

Biotherapy monitoring test CE marking

Theradiag : 07 April, 2015  (New Product)
The Stelara biotherapy monitoring test from Theradiag's Lisa Tracker range has obtained CE marking
Biotherapy monitoring test CE marking


Theradiag, a company specialising in theranostics and in vitro diagnostics, has obtained CE marking for its monitoring test of Stelara (ustekinumab), the 10th biotherapy monitoring test of Theradiag's Lisa Tracker range.

 

Stelara is fully human monoclonal antibody that targets the cytokines (interleukin) IL-12 and IL-23 proteins. It was approved for use in moderate to severe plaque psoriasis and psoriatic arthritis. Psoriasis is a very common autoimmune disease, affecting two-to-three percent of the world's population. Ustekinumab is also currently undergoing clinical trials for the treatment of Crohn's Disease. Sales of Stelara were $1.3 billion in 2014.



"Theradiag is the only company in the world to offer such a large range of monitoring tests for the treatment of autoimmune and inflammatory diseases. To maintain our leadership on the market, we will develop monitoring kits for all available and future biotherapies in the fields of autoimmune diseases and cancer. The CE marking that we announce today, the 10th in our Lisa Tracker range, is a proof of this commitment" concludes Michel Finance, Chief Executive Officer of Theradiag.


Bookmark and Share
 
Home I Editor's Blog I News by Zone I News by Date I News by Category I Special Reports I Directory I Events I Advertise I Submit Your News I About Us I Guides
 
   © 2012 ProHealthServiceZone.com
Netgains Logo